Cargando…

Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses

To evaluate the humoral immune response to mixed Equine Influenza vaccination, a common practice in the field, an experimental study was carried out on 42 unvaccinated thoroughbred weanling foals divided into six groups of seven. Three groups were vaccinated using a non-mixed protocol (Equilis(®) Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dilai, Mohamed, Piro, Mohammed, El Harrak, Mehdi, Fougerolle, Stéphanie, Dehhaoui, Mohammed, Dikrallah, Asmaa, Legrand, Loïc, Paillot, Romain, Fassi Fihri, Ouafaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313876/
https://www.ncbi.nlm.nih.gov/pubmed/30287762
http://dx.doi.org/10.3390/vaccines6040071
_version_ 1783384033236877312
author Dilai, Mohamed
Piro, Mohammed
El Harrak, Mehdi
Fougerolle, Stéphanie
Dehhaoui, Mohammed
Dikrallah, Asmaa
Legrand, Loïc
Paillot, Romain
Fassi Fihri, Ouafaa
author_facet Dilai, Mohamed
Piro, Mohammed
El Harrak, Mehdi
Fougerolle, Stéphanie
Dehhaoui, Mohammed
Dikrallah, Asmaa
Legrand, Loïc
Paillot, Romain
Fassi Fihri, Ouafaa
author_sort Dilai, Mohamed
collection PubMed
description To evaluate the humoral immune response to mixed Equine Influenza vaccination, a common practice in the field, an experimental study was carried out on 42 unvaccinated thoroughbred weanling foals divided into six groups of seven. Three groups were vaccinated using a non-mixed protocol (Equilis(®) Prequenza-Te, Proteqflu-Te(®) or Calvenza-03(®)) and three other groups were vaccinated using a mix of the three vaccines mentioned previously. Each weanling underwent a primary EI vaccination schedule composed of two primary immunisations (V1 and V2) four weeks apart followed by a third boost immunisation (V3) six months later. Antibody responses were monitored until one-year post-V3 by single radial haemolysis (SRH). The results showed similar antibody responses for all groups using mixed EI vaccination and the group exclusively vaccinated with Equilis(®) Prequenza-TE, which were significantly higher than the other two groups vaccinated with Proteqflu-TE(®) and Calvenza-03(®). All weanlings (100%) failed to seroconvert after V1 and 21% (9/42) still had low or no SRH antibody titres two weeks post-V2. All weanlings had seroconverted and exceeded the clinical protection threshold one month after V3. The poor response to vaccination was primarily observed in groups exclusively vaccinated with Proteqflu-Te(®) and Calvenza-03(®). A large window of susceptibility (3–4.5-month duration) usually called immunity gap was observed after V2 and prior to V3 for all groups. The SRH antibody level was maintained above the clinical protection threshold for three months post-V3 for the groups exclusively vaccinated with Proteqflu-Te(®) and Calvenza-03(®), and six months to one year for groups using mixed EI vaccination or exclusively vaccinated with Equilis(®) Prequenza-Te. This study demonstrates for the first time that the mix of EI vaccines during the primary vaccination schedule has no detrimental impact on the correlate of protection against EIV infection.
format Online
Article
Text
id pubmed-6313876
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63138762019-01-07 Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses Dilai, Mohamed Piro, Mohammed El Harrak, Mehdi Fougerolle, Stéphanie Dehhaoui, Mohammed Dikrallah, Asmaa Legrand, Loïc Paillot, Romain Fassi Fihri, Ouafaa Vaccines (Basel) Article To evaluate the humoral immune response to mixed Equine Influenza vaccination, a common practice in the field, an experimental study was carried out on 42 unvaccinated thoroughbred weanling foals divided into six groups of seven. Three groups were vaccinated using a non-mixed protocol (Equilis(®) Prequenza-Te, Proteqflu-Te(®) or Calvenza-03(®)) and three other groups were vaccinated using a mix of the three vaccines mentioned previously. Each weanling underwent a primary EI vaccination schedule composed of two primary immunisations (V1 and V2) four weeks apart followed by a third boost immunisation (V3) six months later. Antibody responses were monitored until one-year post-V3 by single radial haemolysis (SRH). The results showed similar antibody responses for all groups using mixed EI vaccination and the group exclusively vaccinated with Equilis(®) Prequenza-TE, which were significantly higher than the other two groups vaccinated with Proteqflu-TE(®) and Calvenza-03(®). All weanlings (100%) failed to seroconvert after V1 and 21% (9/42) still had low or no SRH antibody titres two weeks post-V2. All weanlings had seroconverted and exceeded the clinical protection threshold one month after V3. The poor response to vaccination was primarily observed in groups exclusively vaccinated with Proteqflu-Te(®) and Calvenza-03(®). A large window of susceptibility (3–4.5-month duration) usually called immunity gap was observed after V2 and prior to V3 for all groups. The SRH antibody level was maintained above the clinical protection threshold for three months post-V3 for the groups exclusively vaccinated with Proteqflu-Te(®) and Calvenza-03(®), and six months to one year for groups using mixed EI vaccination or exclusively vaccinated with Equilis(®) Prequenza-Te. This study demonstrates for the first time that the mix of EI vaccines during the primary vaccination schedule has no detrimental impact on the correlate of protection against EIV infection. MDPI 2018-10-04 /pmc/articles/PMC6313876/ /pubmed/30287762 http://dx.doi.org/10.3390/vaccines6040071 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dilai, Mohamed
Piro, Mohammed
El Harrak, Mehdi
Fougerolle, Stéphanie
Dehhaoui, Mohammed
Dikrallah, Asmaa
Legrand, Loïc
Paillot, Romain
Fassi Fihri, Ouafaa
Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses
title Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses
title_full Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses
title_fullStr Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses
title_full_unstemmed Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses
title_short Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses
title_sort impact of mixed equine influenza vaccination on correlate of protection in horses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313876/
https://www.ncbi.nlm.nih.gov/pubmed/30287762
http://dx.doi.org/10.3390/vaccines6040071
work_keys_str_mv AT dilaimohamed impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses
AT piromohammed impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses
AT elharrakmehdi impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses
AT fougerollestephanie impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses
AT dehhaouimohammed impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses
AT dikrallahasmaa impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses
AT legrandloic impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses
AT paillotromain impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses
AT fassifihriouafaa impactofmixedequineinfluenzavaccinationoncorrelateofprotectioninhorses